Linagliptin - Latest Advances

Linagliptin protects diabetic rats' cognition.

Journal: Lab animal

Published: April 02, 2026

SGLT2 Inhibitor Use and Cardiorenal Outcomes in Type 2 Diabetes With Liver Cirrhosis.

Journal: JAMA network open

Published: February 23, 2026

Renal functional reserve predicts GFR response to empagliflozin in RENALIS and RACELINES clinical trials.

Journal: Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association

Published: February 10, 2026

Effectiveness and Safety of Fixed-Dose Empagliflozin/Linagliptin Combination in Type 2 Diabetes Mellitus: Real-World Evidence From Bangladesh.

Journal: Cureus

Published: January 31, 2026

Comprehensive experimental and computational evaluation of novel linagliptin-analogues: Synthesis, DFT calculations, molecular modeling, and in vitro anticancer/antioxidant activities.

Journal: Computational biology and chemistry

Published: January 29, 2026

Cardiovascular Effects of Alogliptin, Linagliptin, Saxagliptin, and Sitagliptin: A Target Trial Emulation of a Comparative Effectiveness Study.

Journal: Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists

Published: January 25, 2026

Acute Pancreatitis Associated With Semaglutide in a Patient With Multimorbidity: A Case Report.

Journal: Cureus

Published: January 20, 2026

Targeting Neuropeptide Y/DPP4 Signalling Suppresses Ewing Sarcoma Survival and Improves Monocyte Viability.

Journal: International journal of molecular sciences

Published: January 15, 2026

Evaluation of the anti-hyperglycemic, anti-hyperlipidemic, cardioprotective and anti-inflammatory effects of a xanthine-based dipeptidyl peptidase-4 inhibitor and diosmin in NA/STZ-induced diabetic rats.

Journal: Archives of physiology and biochemistry

Published: January 08, 2026

Protective effects of linagliptin and tenofovir disoproxil fumarate against APAP-induced acute liver injury: A biochemical, histological, and computational study.

Journal: Tissue & cell

Published: January 05, 2026

Effectiveness of Empagliflozin-Linagliptin Fixed-Dose Combination on Chronic Kidney Disease Outcomes in Patients With Type 2 Diabetes in a Real-World Setting.

Journal: Cureus

Published: December 25, 2025

Linagliptin loaded chitosan nanoparticles for the efficient therapy of renal fibrosis.

Journal: Frontiers in pharmacology

Published: December 22, 2025